Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions
From Iskomunidad
No edit summary |
mNo edit summary |
||
| Line 9: | Line 9: | ||
Webpage shortcut: '''[http://goo.gl/xszDH goo.gl/xszDH]''' | Webpage shortcut: '''[http://goo.gl/xszDH goo.gl/xszDH]''' | ||
<br /><br /> | <br /><br /> | ||
'''[https://docs.google.com/spreadsheet/viewform?formkey=dFhiejdvN0RuekNkai1IV0ZsVTBfMGc6MQ Online Registration]'''<br /><br /> | '''[https://docs.google.com/spreadsheet/viewform?formkey=dFhiejdvN0RuekNkai1IV0ZsVTBfMGc6MQ Online Registration].''' Please register asap, as seats are limited. Confirmation will be needed.<br /><br /> | ||
'''Resource Person'''<br /> | '''Resource Person'''<br /> | ||
Revision as of 23:49, 26 October 2012
An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
10 December 2012 (Monday), 2pm
Buenafe Hall
College of Medicine
University of the Philippines - Manila
Webpage shortcut: goo.gl/xszDH
Online Registration. Please register asap, as seats are limited. Confirmation will be needed.
Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA
Organizers
- PGC ELSI Program
- UP Manila Research Ethics Review Board
See Also
“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center